Opendata, web and dolomites

SERAS_v4.0 SIGNED

Seizure Risk Asessment for Epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SERAS_v4.0 project word cloud

Explore the words cloud of the SERAS_v4.0 project. It provides you a very rough idea of what is the project "SERAS_v4.0" about.

benchmark    intelligence    everybody    predicting    generation    permanently    27    discrete    brain    suffers    clinically    data    people    caused    create    accident    instrument    accidents    frequency    business    moved    learning    device    intensity    patient    social    life    neuroserveis    care    doctors    live    mobile    reports    vision    artificial    validated    digital    global    monitor    automate    usa    invasive    services    occurs    health    seras    alerts    claim    wearable    neurological    seizures    accelerate    monitoring    serious    continuous    permanent    solution    portable    commercialization    epileptic    world    mjn    time    electroencephalogram    treatments    epilepsy    turnover    cloud    suffered    sme    connected    monitors    market    source    knowing    plan    disruptive    patients    ph2    minute    earpiece    platform    consists    seizure    prediction    pathologies    diseases    quality    depending    signals    medical    recorded    environment    functionalities    algorithm    suffer    reads    65    containing    predicts    million    worldwide    2025   

Project "SERAS_v4.0" data sheet

The following table provides information about the project.

Coordinator
MJN NEUROSERVEIS SL 

Organization address
address: AVENUE JOAN CARLES 184 PLANTA BJS PUERTA DR
city: BLANES
postcode: 17300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 2˙568˙300 €
 EC max contribution 1˙797˙810 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MJN NEUROSERVEIS SL ES (BLANES) coordinator 1˙797˙810.00

Map

 Project objective

MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The device consists of an earpiece that reads the electroencephalogram, and a cloud-connected mobile application containing an artificial intelligence algorithm that alerts the user, their environment, and medical services one minute before a seizure occurs. In addition, the device permanently monitors a patient's brain activity, allowing for the generation of medical reports, the number of seizures suffered, their intensity and frequency. Currently, doctors who care for these patients do not have the data to allow for targeted patient treatments. Today, there is no device clinically validated in the market with these functionalities that can permanently monitor brain activity in a discrete, portable and continuous way. Around 50-65 million people suffers from epilepsy worldwide, depending on source. These people live in a permanent state of uncertainty, caused by not knowing when they will suffer the next seizure and if it could cause a serious accident for them. SERAS is a disruptive solution unique in monitoring brain signals and predicting epilepsy seizures with enough time to avoid accidents. MJN is a business moved by high social impact vision; our claim is ‘Quality of life for everybody’. We face a market of 6 million epileptic people in EU and USA. We aim to become a new benchmark on a global scale in the digital health world related with neurological diseases. SME Instrument Ph2 project will help us to improve our prediction algorithm in order to automate learning process and create a platform to exploit data recorded from users of the device. This will allow us and doctors go a step further on research of neurological pathologies. By Ph2 project we will accelerate our commercialization plan to scale-up our business to the goal of €27 million turnover by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SERAS_V4.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SERAS_V4.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

Presque (2019)

Smart Nursing Bra

Read More